Chugai Pharmaceutical Co., Ltd. is considering reducing its investment unit to enhance stock liquidity and broaden its investor base, and has indicated a policy to carefully determine the necessity and timing of implementation.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4519","jir_company_name":"Chugai Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-03-26","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/4519-20260326-01.pdf","jir_short_summary":"Chugai Pharmaceutical Co., Ltd. is considering reducing its investment unit to enhance stock liquidity and broaden its investor base, and has indicated a policy to carefully determine the necessity and timing of implementation.","jir_summary":"### Thoughts on Reducing Investment Units\nChugai Pharmaceutical Co., Ltd. recognizes that reducing the investment unit contributes to improving stock liquidity and expanding the investor base. It regards this as one of the effective measures.\n\n### Policy on Reducing Investment Units\nRegarding the reduction of the investment unit, the company will carefully consider the necessity and timing of implementation by comprehensively considering stock market trends and the company's stock price levels. This disclosure is made pursuant to Article 409 of the Tokyo Stock Exchange Securities Listing Regulations.","jir_financial_highlights":"Investment Unit: 5 million yen or more (as of 2025-12-31) (Considering reduction)","jir_category":"","jir_hashtags":"#ChugaiPharmaceutical, #CapitalPolicy, #InvestmentUnitReduction, #JapaneseStocks","jir_key_figures":"Investment Unit: 5 million yen or more (as of 2025-12-31)\nConsideration Policy: Carefully determine the necessity and timing of implementation\nDisclosure Basis: Article 409 of the Tokyo Stock Exchange Securities Listing Regulations","jir_meta_title":"Chugai Pharmaceutical Co., Ltd. Announces Policy to Consider Investment Unit Reduction\uff5cAiming to Improve Liquidity","jir_meta_description":"Chugai Pharmaceutical Co., Ltd. is considering reducing its investment unit to enhance stock liquidity and broaden its investor base. The company has indicated it will carefully determine the necessity and timing of implementation.","jir_og_title":"Chugai Pharmaceutical Announces Policy to Consider Investment Unit Reduction","jir_og_description":"Chugai Pharmaceutical Co., Ltd. is considering improving liquidity through investment unit reduction and announced careful consideration of the timing of implementation.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":6836,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-37030","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n